CIK 1343781
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2022-Q3. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 53.25% | 8 |
| Health Care Equipment & Supplies | 41.80% | 6 |
| Unclassified | 4.95% | 8 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | BMRN | BIOMARIN PHARMACEUTICAL INC | Health Care | 34.88% |
| 2 | DXCM | DEXCOM INC | Health Care | 33.35% |
| 3 | CYTK | CYTOKINETICS INC | Health Care | 6.91% |
| 4 | ACRV | Acrivon Therapeutics, Inc. | Health Care | 3.00% |
| 5 | HYPR | Hyperfine, Inc. | Health Care | 2.99% |
| 6 | ALKS | Alkermes plc. | Health Care | 2.63% |
| 7 | CNMD | CONMED Corp | Health Care | 2.23% |
| 8 | NBIX | NEUROCRINE BIOSCIENCES INC | Health Care | 2.19% |
| 9 | SNDX | Syndax Pharmaceuticals Inc | Health Care | 1.63% |
| 10 | CHINOOK THERAPEUTICS INC | Unclassified | 1.44% |
14/22 names classified · sector 95.1% of weight · industry 95.1% · mkt cap 95.1%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 95.1% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 78.5% of book weight (8/15 names) · unclassified 21.5%: CYTK, , ACRV, HYPR, SNDX, GERN, RCKT. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | BMRNBIOMARIN PHARMACEUTICAL INC | 367,765 | $38M | 34.9% | TRIM −52% |
| 2 | DXCMDEXCOM | 321,380 | $36M | 33.4% | ADD 27% |
| 3 | CYTKCYTOKINETICS INC | 164,440 | $8M | 6.9% | TRIM −62% |
| 4 | ACRVACRIVON THERAPEUTICS INC | 284,201 | $3M | 3.0% | NEW |
| 5 | HYPRHYPERFINE INC | 3,880,900 | $3M | 3.0% | ADD 41% |
| 6 | ALKSALKERMES PLC | 110,000 | $3M | 2.6% | TRIM −64% |
| 7 | CNMDCONMED CORP | 27,500 | $2M | 2.2% | NEW |
| 8 | NBIXNEUROCRINE BIOSCIENCES INC | 20,000 | $2M | 2.2% | TRIM −8% |
| 9 | SNDXSYNDAX PHARMACEUTICALS INC | 70,000 | $2M | 1.6% | TRIM −92% |
| 10 | CHINOOK THERAPEUTICS INC | 60,000 | $2M | 1.4% | TRIM −78% |
| 11 | ISRGINTUITIVE SURGICAL INC | 5,750 | $2M | 1.4% | NEW |
| 12 | BLUEPRINT MEDICINES CORP | 30,000 | $1M | 1.2% | TRIM −71% |
| 13 | GERNGERON CORP | 500,000 | $1M | 1.1% | TRIM −74% |
| 14 | PENPENUMBRA INC | 5,000 | $1M | 1.0% | NEW |
| 15 | RCKTROCKET PHARMACEUTICALS INC | 50,000 | $978,500 | 0.9% | TRIM −89% |
| 16 | RAIN ONCOLOGY INC | 120,000 | $960,000 | 0.9% | NEW |
| 17 | INSPINSPIRE MED SYS INC | 3,500 | $881,580 | 0.8% | TRIM −91% |
| 18 | SILK ROAD MEDICAL INC | 15,000 | $792,750 | 0.7% | NEW |
| 19 | IMMUNOGEN INC | 150,000 | $744,000 | 0.7% | TRIM −88% |
| 20 | EQRX INC | 35,239 | $9,451 | 0.0% | HOLD |
| 21 | EUCRATES BIOMEDICAL ACQU COR | 78,059 | $4,340 | 0.0% | HOLD |
| 22 | MEDICUS SCIENCES ACQUISITION | 29,776 | $2,679 | 0.0% | HOLD |
Where this firm's principals came from and which firms its alumni went on to found.
